PortfoliosLab logoPortfoliosLab logo
BNY vs. CVS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

BNY vs. CVS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in The Bank of New York Mellon Corporation (BNY) and CVS Health Corporation (CVS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BNY achieves a 22.11% return, which is significantly higher than CVS's 17.10% return. Over the past 10 years, BNY has outperformed CVS with an annualized return of 15.90%, while CVS has yielded a comparatively lower 2.58% annualized return.


BNY

1D
-0.50%
1M
6.59%
YTD
22.11%
6M
25.35%
1Y
60.34%
3Y*
52.65%
5Y*
25.33%
10Y*
15.90%

CVS

1D
2.09%
1M
11.41%
YTD
17.10%
6M
23.91%
1Y
48.94%
3Y*
13.62%
5Y*
4.52%
10Y*
2.58%
*Multi-year figures are annualized to reflect compound growth (CAGR)

BNY vs. CVS - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
BNY
The Bank of New York Mellon Corporation
22.11%54.45%51.90%18.52%-19.14%40.55%-12.91%9.56%-10.85%15.68%
CVS
CVS Health Corporation
17.10%84.35%-40.77%-12.53%-7.63%54.87%-5.14%17.26%-7.04%-5.75%

Correlation

The correlation between BNY and CVS is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.07

Correlation (3Y)
Calculated over the trailing 3-year period

0.20

Correlation (5Y)
Calculated over the trailing 5-year period

0.32

Correlation (10Y)
Calculated over the trailing 10-year period

0.35

Correlation (All Time)
Calculated using the full available price history since Dec 18, 1984

0.32

Over the past year, the correlation between BNY and CVS has dropped to 0.07 - well below their long-term average of 0.32, suggesting their price drivers have been diverging.

Fundamentals

Market Cap

BNY:

$98.14B

CVS:

$116.86B

EPS

BNY:

$8.43

CVS:

$2.30

PE Ratio

BNY:

16.67

CVS:

39.69

PS Ratio

BNY:

2.44

CVS:

0.29

PB Ratio

BNY:

2.49

CVS:

1.51

Total Revenue (TTM)

BNY:

$40.65B

CVS:

$407.91B

Gross Profit (TTM)

BNY:

$20.54B

CVS:

$56.59B

EBITDA (TTM)

BNY:

$8.96B

CVS:

$9.99B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BNY vs. CVS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BNY
BNY Risk / Return Rank: 9494
Overall Rank
BNY Sharpe Ratio Rank: 9595
Sharpe Ratio Rank
BNY Sortino Ratio Rank: 9393
Sortino Ratio Rank
BNY Omega Ratio Rank: 9393
Omega Ratio Rank
BNY Calmar Ratio Rank: 9393
Calmar Ratio Rank
BNY Martin Ratio Rank: 9494
Martin Ratio Rank

CVS
CVS Risk / Return Rank: 8080
Overall Rank
CVS Sharpe Ratio Rank: 8383
Sharpe Ratio Rank
CVS Sortino Ratio Rank: 7575
Sortino Ratio Rank
CVS Omega Ratio Rank: 7979
Omega Ratio Rank
CVS Calmar Ratio Rank: 8282
Calmar Ratio Rank
CVS Martin Ratio Rank: 8282
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BNY vs. CVS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for The Bank of New York Mellon Corporation (BNY) and CVS Health Corporation (CVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


BNYCVSDifference

Sharpe ratio

Return per unit of total volatility

3.06

1.60

+1.47

Sortino ratio

Return per unit of downside risk

3.78

2.02

+1.75

Omega ratio

Gain probability vs. loss probability

1.50

1.31

+0.19

Calmar ratio

Return relative to maximum drawdown

5.98

2.99

+2.98

Martin ratio

Return relative to average drawdown

16.93

7.71

+9.22

BNY vs. CVS - Sharpe Ratio Comparison

The current BNY Sharpe Ratio is 3.06, which is higher than the CVS Sharpe Ratio of 1.60. The chart below compares the historical Sharpe Ratios of BNY and CVS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


BNYCVSDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

3.06

1.60

+1.47

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

1.04

0.15

+0.88

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.59

0.09

+0.50

Sharpe Ratio (All Time)

Calculated using the full available price history

0.36

0.33

+0.03

Drawdowns

BNY vs. CVS - Drawdown Comparison

The maximum BNY drawdown since its inception was -72.28%, which is greater than CVS's maximum drawdown of -64.07%. Use the drawdown chart below to compare losses from any high point for BNY and CVS.


Loading charts...

Drawdown Indicators


BNYCVSDifference

Max Drawdown

Largest peak-to-trough decline

-72.28%

-64.07%

-8.21%

Max Drawdown (1Y)

Largest decline over 1 year

-10.15%

-16.44%

+6.29%

Max Drawdown (3Y)

Largest decline over 3 years

-17.58%

-43.98%

+26.40%

Max Drawdown (5Y)

Largest decline over 5 years

-40.45%

-56.79%

+16.34%

Max Drawdown (10Y)

Largest decline over 10 years

-50.49%

-56.79%

+6.30%

Current Drawdown

Current decline from peak

-1.42%

-6.87%

+5.45%

Average Drawdown

Average peak-to-trough decline

-18.72%

-19.56%

+0.84%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.58%

6.37%

-2.79%

Volatility

BNY vs. CVS - Volatility Comparison

The current volatility for The Bank of New York Mellon Corporation (BNY) is 4.87%, while CVS Health Corporation (CVS) has a volatility of 11.02%. This indicates that BNY experiences smaller price fluctuations and is considered to be less risky than CVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BNYCVSDifference

Volatility (1M)

Calculated over the trailing 1-month period

4.87%

11.02%

-6.15%

Volatility (6M)

Calculated over the trailing 6-month period

15.73%

26.04%

-10.31%

Volatility (1Y)

Calculated over the trailing 1-year period

19.79%

30.79%

-11.00%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

24.58%

29.91%

-5.33%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

27.04%

29.28%

-2.24%

Dividends

BNY vs. CVS - Dividend Comparison

BNY's dividend yield for the trailing twelve months is around 1.51%, less than CVS's 2.91% yield.


PositionTTM20252024202320222021202020192018201720162015
BNY
The Bank of New York Mellon Corporation
1.51%1.72%2.32%3.04%3.12%2.24%2.92%2.34%2.21%1.60%1.52%1.65%
CVS
CVS Health Corporation
2.91%3.35%5.93%3.06%2.36%1.94%2.93%2.69%3.05%2.76%2.15%1.43%

Financials

BNY vs. CVS - Financials Comparison

This section allows you to compare key financial metrics between The Bank of New York Mellon Corporation and CVS Health Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B100.00B20222023202420252026
9.86B
100.43B
(BNY) Total Revenue
(CVS) Total Revenue
Values in USD except per share items

BNY vs. CVS - Profitability Comparison

The chart below illustrates the profitability comparison between The Bank of New York Mellon Corporation and CVS Health Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%100.0%20222023202420252026
54.9%
15.6%
Portfolio components
BNY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, The Bank of New York Mellon Corporation reported a gross profit of 5.42B and revenue of 9.86B. Therefore, the gross margin over that period was 54.9%.

CVS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, CVS Health Corporation reported a gross profit of 15.62B and revenue of 100.43B. Therefore, the gross margin over that period was 15.6%.

BNY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, The Bank of New York Mellon Corporation reported an operating income of 2.02B and revenue of 9.86B, resulting in an operating margin of 20.4%.

CVS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, CVS Health Corporation reported an operating income of 4.68B and revenue of 100.43B, resulting in an operating margin of 4.7%.

BNY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, The Bank of New York Mellon Corporation reported a net income of 1.63B and revenue of 9.86B, resulting in a net margin of 16.6%.

CVS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, CVS Health Corporation reported a net income of 2.94B and revenue of 100.43B, resulting in a net margin of 2.9%.


Frequently Asked Questions


BNY and CVS have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CVS has higher volatility (11.02%) compared to BNY (4.87%). In terms of maximum drawdown, BNY dropped -72.28% vs CVS's -64.07%.

BNY currently has the higher Sharpe Ratio (3.06 vs 1.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BNY and CVS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer